Results 141 to 150 of about 1,484,561 (230)

The relationship of soluble urokinase plasminogen activator receptor levels with preterm premature rupture of membranes and predictive value in neonatal intensive care unit admission. [PDF]

Rev Assoc Med Bras (1992)
Koc BL, Tanacan A, Haliloglu E, Yilmaz HE, Ersak DT, Aktas BA, Aktas BA, Kara O, Sahin D.   +8 more
europepmc   +1 more source

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Mediates the Impact of Diabetes on Adverse Outcomes in Coronary Artery Disease. [PDF]

Diabetes Care
Sakr SM, Desai S, Medina-Inojosa J, Liu C, Razavi AC, Yadalam AK, Ko YA, Ahmed T, Harris KA, Huang J, Yeboah R, Haroun N, Hartsfield JD, Owais M, Lodhi R, Eldaidamouni AA, Al Kasem M, Ali MK, Narayan KMV, Pasquel FJ, Tandon N, Mohan V, Quyyumi AA.   +22 more
europepmc   +1 more source

Soluble Urokinase Plasminogen Activator Receptor (suPAR): Role in the Risk Stratification of Potentially Infected Patients Presenting at the Emergency Department. [PDF]

Diagnostics (Basel)
Baldetti M, Velocci S, Belardi R, Di Lecce VN, Paganelli C, Fortunato NA, Ricciardulli T, Terrinoni A, Pieri M, Bernardini S, Legramante JM, Minieri M.   +11 more
europepmc   +1 more source

Soluble urokinase plasminogen activator receptor and acute kidney injury in hematopoietic cell transplantation. [PDF]

Blood Adv
Bhasin-Chhabra B, Wang T, Levine JE, Shenoy S, Perales MA, Bashey A, Raff H, Saber W.   +7 more
europepmc   +1 more source

Letter to the editor: Soluble urokinase plasminogen activator receptor and outcomes in HFpEF: A TOPCAT ancillary study. [PDF]

ESC Heart Fail
Raza A, Gulfishan S.
europepmc   +1 more source

Soluble urokinase plasminogen activator receptor and outcomes in HFpEF: A TOPCAT ancillary study. [PDF]

ESC Heart Fail
Hutten CG, Tekumulla A, Ismail A, Vasbinder A, Farhat T, Kunkle P, Goonewardena SN, Abdel-Latif A, Pitt B, Hayek SS.   +9 more
europepmc   +1 more source

Transdiagnostic determinants of Growth Differentiation Factor-15 (GDF-15) in psychiatric in-patients: age, renal indices, interleukin-6 (IL-6) and soluble urokinase plasminogen activator receptor (suPAR). [PDF]

Brain Behav Immun Health
Tsapakis EM, Keskilidou E, Karapatis A, Kyziridis T, Prokopiou P, Karalazou P, Thisiadou A, Makedou K, Fountoulakis KN.   +8 more
europepmc   +1 more source

Reversal of filarial serpin Wb123-urokinase plasminogen activator receptor mediated alternative macrophage activation by monoclonal antibody. [PDF]

PLoS Negl Trop Dis
Upadhyay P, Munjal A, Mondal A, Singh G, Mukherjee S, Siwach S, Chandoulla M, Kaushik MC, Gupta PK, Pati S, Singh S.   +10 more
europepmc   +1 more source

Maternal soluble urokinase plasminogen activator receptor levels in intrahepatic cholestasis of pregnancy: a predictor of neonatal intensive care unit admission. [PDF]

Rev Assoc Med Bras (1992)
Aktaş BA, Aktaş BA, Agaoglu Z, Peker BN, Başaran E, Orhan N, Özdal BB, Şahin D.   +7 more
europepmc   +1 more source

Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Erectile Dysfunction in Diabetic Patients. [PDF]

J Clin Med
Erinc O, Yilmaz O, Kaya TY, Algemi M, Akarsu M.   +4 more
europepmc   +1 more source